Botanical species · safety record

Adenium obesum

The EFSA Compendium of Botanicals holds 11 constituent measurements for Adenium obesum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Adenium obesum (Forssk.) Roem. & Schult.

11Constituent measurements

0Safety records

7Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
16-anhydrogitoxigenin	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
16-anhydrogitoxigenin	Stem / stalk	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Cardiac glycosides	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Cardiac glycosides	Leaves	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
Isoquercitrin	Leaves	Solvent extraction	0.26 Milligram/gram	HPLC-UV	Resolve DOI
Cardiac glycosides	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Cardiac glycosides	Stem / stalk	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Pregnane derivatives	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Pregnane derivatives	Stem / stalk	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Saponins	Bark	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Versiani, Muhammad Ali., Ahmed, Salman Khalid., Ikram, Ambreen., Ali, Syed Tahir., Yasmeen, Kousar., Faizi, Shaheen. Chemical Constituents and Biological Activities of Adenium obesum (Forsk.) Roem. et Schult. . Chemistry & biodiversity, 2014, vol. 11, no. 2, p. 171-180. DOI
VETHAVIYASAR, N., JOHN, D. 16-ANHYDRO-3-ACETYL-GITOXIGENIN IN ADENIUM-OBESUM. Planta medica, 1982, vol. 44, no. 2, p. 123-124. DOI
YAMAUCHI, T., ABE, F. CARDIAC-GLYCOSIDES AND PREGNANES FROM ADENIUM-OBESUM (STUDIES ON THE CONSTITUENTS OF ADENIUM .1.) . Chemical & pharmaceutical bulletin, 1990, vol. 38, no. 3, p. 669-672.
Ahmed, Salman Khalid., Versiani, Muhammad Ali., Ikram, Ambreen., Sattar, Samina Abdul., Faizi, Shaheen. Cytotoxic cardiac glycosides from the fruit (pods) of Adenium obesum (Forssk.) Roem. & Schult . Natural product research, 2017, vol. 31, no. 10, p. 1205-1208. DOI
Arai, Midori A., Tateno, Chikashi., Koyano, Takashi., Kowithayakorn, Thaworn., Kawabe, Seiichiro., Ishibashi, Masami. New hedgehog/GLI-signaling inhibitors from Adenium obesum. Organic & biomolecular chemistry, 2011, vol. 9, no. 4, p. 1133-1139. DOI
Meda, N. R., Fraisse, D., Gnoula, C., Peyrode, C., Texier, O., Senejoux, F., Felgines, C. Characterization and Quantification of Polyphenolic Compounds from Adenium Obesum Leaves . Chemistry of natural compounds, 2016, vol. 52, no. 1, p. 134-135. DOI
ALYAHYA, MA., MOSSA, JS., TARIQ, M., ALMESHAL, IA., ALBADR, AA. PHYTOTOXICITY STUDIES ON SAUDI PLANTS. Toxicon, 1987, vol. 25, no. 4, p. 363-364.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature